Sinphar Pharmaceutical Co.,Ltd.

TWSE:1734 Stock Report

Market Cap: NT$5.6b

Sinphar PharmaceuticalLtd Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Sinphar PharmaceuticalLtd.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Pharmaceuticals earnings growth59.5%
Revenue growth raten/a
Future return on equityn/a
Analyst coverage

None

Last updatedn/a

Recent future growth updates

No updates

Recent updates

Impressive Earnings May Not Tell The Whole Story For Sinphar PharmaceuticalLtd (TWSE:1734)

Apr 02
Impressive Earnings May Not Tell The Whole Story For Sinphar PharmaceuticalLtd (TWSE:1734)

Would Sinphar PharmaceuticalLtd (TPE:1734) Be Better Off With Less Debt?

Feb 15
Would Sinphar PharmaceuticalLtd (TPE:1734) Be Better Off With Less Debt?

Can You Imagine How Sinphar PharmaceuticalLtd's (TPE:1734) Shareholders Feel About The 52% Share Price Increase?

Dec 22
Can You Imagine How Sinphar PharmaceuticalLtd's (TPE:1734) Shareholders Feel About The 52% Share Price Increase?

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Sinphar PharmaceuticalLtd has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

TWSE:1734 - Analysts future estimates and past financials data (TWD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
9/30/20243,045333255546N/A
6/30/20243,01136162403N/A
3/31/20242,96940567423N/A
12/31/20232,963375-5296N/A
9/30/20232,97727732304N/A
6/30/20232,970269151361N/A
3/31/20232,959247190353N/A
12/31/20222,857225272425N/A
9/30/20222,735198196357N/A
6/30/20222,59397148308N/A
3/31/20222,48515-15145N/A
12/31/20212,434-38-26136N/A
9/30/20212,333-77-33119N/A
6/30/20212,405-53-8478N/A
3/31/20212,380-50-51112N/A
12/31/20202,388-29-11146N/A
9/30/20202,52060-146-13N/A
6/30/20202,45860-183-16N/A
3/31/20202,44726-215-19N/A
12/31/20192,39514-256-79N/A
9/30/20192,322-13-21747N/A
6/30/20192,272-17-22617N/A
3/31/20192,2296-19320N/A
12/31/20182,2169-17680N/A
9/30/20182,18623-77118N/A
6/30/20182,19252N/A183N/A
3/31/20182,18662N/A228N/A
12/31/20172,13437N/A220N/A
9/30/20172,15956N/A164N/A
6/30/20172,15836N/A191N/A
3/31/20172,14024N/A96N/A
12/31/20162,13417N/A87N/A
9/30/20162,19042N/A272N/A
6/30/20162,15931N/A198N/A
3/31/20162,20824N/A291N/A
12/31/20152,18714N/A281N/A
9/30/20152,2392N/A117N/A
6/30/20152,236-4N/A74N/A
3/31/20152,44476N/A149N/A
12/31/20142,642163N/A149N/A
9/30/20142,654142N/A187N/A
6/30/20142,910253N/A455N/A
3/31/20142,772241N/A309N/A
12/31/20132,578301N/A297N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if 1734's forecast earnings growth is above the savings rate (1.1%).

Earnings vs Market: Insufficient data to determine if 1734's earnings are forecast to grow faster than the TW market

High Growth Earnings: Insufficient data to determine if 1734's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if 1734's revenue is forecast to grow faster than the TW market.

High Growth Revenue: Insufficient data to determine if 1734's revenue is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if 1734's Return on Equity is forecast to be high in 3 years time

Discover growth companies

7D

1Y

7D

1Y

7D

1Y